Nu SkinNUS
NUS
About: Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Employees: 15,200
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
8% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 50
0% more funds holding
Funds holding: 203 [Q2] → 203 (+0) [Q3]
6% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 64
9.01% less ownership
Funds ownership: 87.3% [Q2] → 78.29% (-9.01%) [Q3]
37% less capital invested
Capital invested by funds: $457M [Q2] → $287M (-$170M) [Q3]
84% less call options, than puts
Call options by funds: $94K | Put options by funds: $577K
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$6.75
4%
downside
Avg. target
$6.88
2%
downside
High target
$7
0%
upside
2 analyst ratings
0 positive
0%
2 neutral
100%
0 negative
0%
DA Davidson Linda Bolton Weiser 38% 1-year accuracy 39 / 104 met price target | 0%downside $7 | Neutral Maintained | 20 Dec 2024 |
Citigroup Chasen Bender 0% 1-year accuracy 0 / 1 met price target | 4%downside $6.75 | Neutral Maintained | 22 Oct 2024 |
Financial journalist opinion
Based on 7 articles about NUS published over the past 30 days
Positive
Zacks Investment Research
6 days ago
NUS Q4 Preliminary Revenues Reach Top End of Outlook, Stock Gains 9.8%
Nu Skin's shares rally as the company stated that its preliminary revenues for Q4 came in at the upper end of its projected range.
Neutral
Business Wire
1 week ago
Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced Q4 2024 preliminary revenue at the high end of the company's guidance range ahead of its presentation at the ICR Conference on Tuesday, Jan. 14. President and CEO Ryan Napierski and CFO James Thomas will participate in a moderated fireside chat to discuss company strategy and the state of the business, including the recent strategic transaction of Mavely for $250 million. The company's presentation will be webcas.
Neutral
Business Wire
1 week ago
NUS Pilots First-in-Market Green Bond Reporting Tokenisation Initiative with Northern Trust and UOB
SINGAPORE--(BUSINESS WIRE)-- #assetmanagement--The National University of Singapore (NUS), Northern Trust and UOB are proud to announce a groundbreaking collaboration to launch a first-in-market initiative aimed at tokenising green bond credentials. NUS is the first university in Singapore to implement blockchain technology for environmental, social, and governance (ESG) reporting. This initiative, a key milestone in green finance innovation, will leverage blockchain technology to enhance transparency, data integ.
Neutral
Seeking Alpha
1 week ago
Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth
Nu Skin Enterprises sold its Mavely affiliate marketing platform for $250 million, achieving a 5x ROI since 2021, and plans to use the cash for debt reduction and innovation. The new cash influx could accelerate both inorganic and organic growth, with potential acquisitions enhancing revenue and free cash flow growth. NUS could benefit from potential tax reductions under the new U.S. administration, which may increase net income and stock demand.
Positive
Zacks Investment Research
2 weeks ago
What Does Nu Skin's Mavely Sale Mean for Its Long-Term Strategy?
NUS' subsidiary has sold its Mavely affiliate marketing platform to Later for nearly $250 million, boosting innovation and resources.
Neutral
Business Wire
2 weeks ago
Nu Skin Enterprises Announces Strategic Transaction of Mavely for $250 Million
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced that its Rhyz Inc. subsidiary completed a strategic transaction with Later, a portfolio company of Summit Partners. As part of the transaction, Rhyz sold its Mavely affiliate marketing technology platform to Later in exchange for approximately $250 million in the form of cash and a minority equity stake in the combined Later/Mavely business. Approximately $33 million of such consideration will be paid to other eq.
Neutral
PRNewsWire
2 weeks ago
Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social
BOSTON , Jan. 3, 2025 /PRNewswire/ -- Later, a leader in influencer marketing and social media management software and services, today announced its acquisition of Mavely, the leading Everyday Influencer Platform.® This acquisition accelerates Later's ability to deliver full-funnel impact and measurable ROI for marketers while enabling creators to maximize their earnings through social commerce.
Negative
Zacks Investment Research
1 month ago
Nu Skin Stock Sinks 40% in Six Months: Hold Steady or Time to Exit?
Nu Skin is struggling with a difficult macroeconomic landscape, volatile currency movements and pressures in the direct selling industry.
Positive
Seeking Alpha
2 months ago
Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation
Nu Skin Enterprises, Inc. demonstrates a tested business model with long-term free cash flow generation, supported by acquisitions, new products, and digital transformation. Despite recent earnings disappointments, optimistic 2025-2026 EPS growth projections and multiple revenue catalysts suggest significant upside potential in the company's valuation. The company's global market expansion, cash acquisitions of LifeDNA and BeautyBio, and innovative product launches are key drivers for future net sales growth.
Negative
Zacks Investment Research
2 months ago
Nu Skin Q3 Earnings & Sales Miss Estimates, 2024 Guidance Cut
NUS' Q3 results show lower earnings and net sales amid macroeconomic pressures and challenges in the direct selling industry. Management lowers 2024 view.
Charts implemented using Lightweight Charts™